Article Text

PDF
Reactive haemophagocytic syndrome in adult-onset Still’s disease: a report of six patients and a review of the literature
  1. J-B Arlet1,
  2. D Le Thi Huong1,
  3. A Marinho1,
  4. Z Amoura1,
  5. B Wechsler1,
  6. T Papo2,
  7. J-C Piette1
  1. 1Department of Internal Medicine, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
  2. 2Department of Internal Medicine, Hôpital Bichat-Claude Bernard, Paris
  1. Correspondence to:
    J-B Arlet
    15 rue du Puits de l’Ermite, 75005 Paris, France; jb.arlet{at}libertysurf.fr

Abstract

Objective: To examine the prevalence and characteristics of patients with reactive haemophagocytic syndrome (RHS) complicating adult-onset Still’s disease (AOSD).

Methods: Of 50 patients with AOSD fulfilling Yamaguchi and Fautrel criteria followed in our department, clinical and laboratory data, course and treatment of six patients with histologically proven RHS and without any obvious cause other than AOSD were retrospectively recorded.

Results: RHS led to AOSD in two cases, whereas it appeared after a mean duration of 3.5 years from onset of AOSD in the other cases. The main symptoms were fever (n = 6), polyarthralgias or myalgias (n = 4), lymphadenopathy or splenomegaly (n = 3), pharyngitis (n = 3), rash (n = 3), pleuritis (n = 3), hepatomegaly (n = 1), normal or low leucocyte count (n = 4), anaemia (n = 6), lymphocytopenia (n = 6), thrombocytopenia (n = 4), hyperbasophilic lymphocytes (n = 2), abnormal liver function tests (n = 6) and increased serum triglyceride level (n = 6). Serum ferritin concentration was constantly increased (>10 000 µg/l in five cases, with <5–35% in glycosylated form). Two patients presented with coagulopathy. Treatment comprised corticosteroids (n = 4) and intravenous immunoglobulins (n = 3), whereas prednisone was unchanged in one case. One death due to pneumonia occurred 15 days after RHS. With a follow-up ranging from 2 to 7.5 years, the other patients were in remission with prednisone plus etanercept (n = 1), prednisone plus methotrexate (n = 1), low-dose prednisone (n = 2) or without treatment (n = 1).

Conclusion: RHS is not uncommon in AOSD. It should be evoked in a patient with AOSD in the absence of hyperleucocytosis, thrombocytopenia, lymphopenia and coagulopathy, or in the presence of high serum ferritin and triglyceride levels.

  • AOSD, adult-onset Still’s disease
  • ARDS, acute respiratory distress syndrome
  • DIC, disseminated intravascular coagulopathy
  • IVIG, intravenous immunoglobulin
  • RHS, reactive haemophagocytic syndrome
  • SOJIA, systemic onset juvenile idiopathic arthritis
  • TNFα, tumour necrosis factor α

Statistics from Altmetric.com

Footnotes

  • Published Online First 15 March 2006

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.